Specification: 5 million IU/botton
Features: This product is a white loose object, which is a clear liquid after dissolution.
Product features: broad-spectrum anti-virus, improve immunity, anti-tumor, anti-bacterial, anti-parasitic.Pharmacological action: Recombinant canine interferon alpha mutant is a new generation of canine interferon alpha product with high activity. It has a broad-spectrum antiviral effect: it inhibits intracellular viral replication and proliferation, and it can be effectively inhibited regardless of natural virus or mutant virus. It has the function of improving immunity, promoting the function of macrophages, lymphocytes and NK cells of the body, and can remove extracellular viruses. Therefore, it has an intracellular and extracellular dual antiviral effect.
Indications: canine viral diseases, including: canine distemper, canine parvovirus enteritis, canine adenovirus, canine parainfluenza, canine coronavirus infection, canine herpesvirus infection, canine viral keratitis and other viral diseases.
Usage and dosage: Each was dissolved in 1 ml of sterile water for injection, injected intramuscularly or subcutaneously. The recommended dose is 20 to 500,000 IU/kg body weight per day, once a day, 1 week for a course of treatment, or as directed by your doctor.
Adverse reactions: The use of this product occasionally cause allergic symptoms such as elevated body temperature, adverse reactions mostly disappeared 48 hours after injection.
Precautions: Do not use if there is any abnormality such as turbidity or sedimentation after dissolution. The damaged product of the bottle cannot be used. For allergic dogs, a skin test should be performed before initial use.
Storage: 2～8 °C cold storage
